Scott Frommer | VP, IR |
David King | Chairman, CEO & President |
Glenn Eisenberg | CFO & EVP |
John Ratliff | CEO, Covance Drug Development |
Ross Muken | Evercore ISI |
Jack Meehan | Barclays Bank |
Kevin Ellich | Craig-Hallum Capital Group |
Lisa Gill | JPMorgan Chase & Co. |
Erin Wright | Crédit Suisse |
Patrick Donnelly | Goldman Sachs Group |
Ralph Giacobbe | Citigroup |
Daniel Leonard | Deutsche Bank |
Rivka Goldwasser | Morgan Stanley |
Kevin Caliendo | UBS Investment Bank |
Donald Hooker | KeyBanc Capital Markets |
Derik De Bruin | Bank of America Merrill Lynch |
Brian Tanquilut | Jefferies |
William Quirk | Piper Jaffray Companies |
Mark Massaro | Canaccord Genuity Limited |
Good day, ladies and gentlemen, and welcome to the LabCorp Q4 2018 Earnings Conference Call. [Operator Instructions].
As a reminder, this conference is being recorded. I would now like to introduce your host for today's conference, Scott Frommer, Vice President of Investor Relations.
You may begin.